Form 4 for VRTX Vertex Pharmaceuticals
Accepted 2024-08-02 00:00:00 ET · period of report 2024-08-01 · accession 0000875320-24-000200 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-08-02 | 2024-08-01 | VRTX | SACHS BRUCE I | Dir | M - OptEx | $125.71 | +5,295 | 45.3K | +13% | +$665.6K |
| D | 2024-08-02 | 2024-08-01 | VRTX | SACHS BRUCE I | Dir | S - Sale+OE | $508.00 | -5,295 | 40.0K | -12% | -$2.69M |
| D | 2024-08-02 | 2024-08-01 | VRTX | SACHS BRUCE I | Dir | M - OptEx | $0.00 | -5,295 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-08-01 | M | A | 5,295 | $125.71 | 45,295 | D | — | — | |
| 2 | Common | Common Stock | 2024-08-01 | S | D | 5,295 | $508.00 | 40,000 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2024-08-01 | M | D | 5,295 | $0.00 | 0 | D | $125.71 · — to 2027-05-31 | 5,295 Common Stock | (F2) Fully vested. |